Skip to Content
Merck
  • In vitro synergistic effects of baicalin with oxytetracycline and tetracycline against Staphylococcus aureus.

In vitro synergistic effects of baicalin with oxytetracycline and tetracycline against Staphylococcus aureus.

The Journal of antimicrobial chemotherapy (2011-03-23)
Pavel Novy, Jan Urban, Olga Leuner, Jaroslav Vadlejch, Ladislav Kokoska
ABSTRACT

In this study we examined the in vitro synergistic effect of baicalin, the flavone constituent of Scutellaria spp., in combinations with oxytetracycline and tetracycline on the growth of Staphylococcus aureus. The MICs were determined by the broth microdilution method and the effect of combinations was evaluated according to the sum of fractional inhibitory concentration indices (FICIs). Synergistic activity (FICI  ≤  0.5) was observed for combinations of baicalin with oxytetracycline or tetracycline against 4 of 10 strains tested, whereas the baicalin/oxytetracycline combination possessed the strongest synergistic effect (FICI = 0.418). Baicalin acts synergistically with oxytetracycline and tetracycline, enhancing its antimicrobial activity against S. aureus, including methicillin- and tetracycline-resistant strains.

MATERIALS
Product Number
Brand
Product Description

Millipore
Oxytetra Selective Supplement, suitable for microbiology